T. Barzu et al., CHARACTERIZATION OF RAT AORTIC SMOOTH-MUSCLE CELLS RESISTANT TO THE ANTIPROLIFERATIVE ACTIVITY OF HEPARIN FOLLOWING LONG-TERM HEPARIN TREATMENT, Journal of cellular physiology, 160(2), 1994, pp. 239-248
Vascular smooth muscle cells (SMC) do not represent a homogeneous popu
lation (Schwartz et al., 1990, Am. J. Pathol. 136:1417-1428). Cellular
clones resistant to the antiproliferative activity of heparin were is
olated from rat aortic SMC cultures (Pukac et al., 1990, Cell Regul.,
1:435-443; San Antonio et al., 1993, Arterioscler. Thromb., 73:748-757
) and from explant of human arterial restenotic lesions (Chan et al.,
1993, Lancet, 341:341-342). We have shown in the present study that lo
ng-term treatment (growth medium supplemented with 200 mu g/ml heparin
, from the second to the tenth passage) of rat aortic SMC, without cel
l cloning, resulted in a significant loss of sensitivity to the growth
inhibition by heparin and its derivatives. The heparin resistance was
stable after growing cells for two passages in heparin-free medium, s
uggesting the selection of a particular phenotype. We tried to charact
erize these cells and to determine the causes of the resistance to the
growth inhibition by heparin. Heparin-treated SMC (HT-SMC) were small
er than their control culture at the same passage, expressed less alph
a-SM actin, and did not overgrow after reaching confluence. As in the
heparin-resistant clones (San Antonio et al., 1993, Cell Regul., 1:435
-443) expression of alpha-SM actin could be increased in HT-SMC by hep
arin addition before Western blotting. Heparin resistance was associat
ed with a tenfold decrease in [H-3]-heparin binding capacity (B-max =
1.9 x 10(6) sites per cell) compared to control cultures (B-max = 1.7
x 10(7) sites per cell), which was irreversible after growing the cell
s for two additional passages in heparin-free medium. We also investig
ated protein kinase C (PKC) in HT-SMC in terms of both enzymatic activ
ity and protein expression (evaluated by [H-3]-staurosporine and [H-3]
-phorbol-12,13-dibutyrate binding). We found that HT-SMC had only half
the PKC activity and expression as control SMC. Therefore, long-term
treatment of rat aortic SMC with heparin allowed the selection of a le
ss differentiated subpopulation of cells, exhibiting low sensitivity t
o the growth inhibition by heparin, which could be related to the low
capacity of binding heparin and to a lower PKC activity and/or express
ion. (C) 1994 Wiley-Liss, Inc.